No plans to get into vaccine production as it requires separate manufacturing infrastructure: Sun Pharma
NEW DELHI: Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require...
NEW DELHI: Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require...
NEW DELHI: Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in...
NEW DELHI: The Serum Institute of India (SII), which manufactures the AstraZeneca coronavirus (Covid-19) vaccine, is planning to start vaccine...
NEW DELHI: Serum Institute of India (SII) CEO Adar Poonawalla on Friday said the US needs to lift its embargo...
NEW DELHI: Serum Institute of India (SII) would require around Rs 3,000 crore to ramp up production capacity for making...